etanercept products — Medica

Initial criteria

• age > 2 years
• Medication is prescribed by or in consultation with a rheumatologist or a dermatologist

Reauthorization criteria

• Patient has been established on therapy for at least 6 months
• When assessed by at least one objective measure, patient experienced a beneficial clinical response from baseline OR patient experienced an improvement in at least one symptom (e.g., less joint pain, morning stiffness, or fatigue; improved function or activities of daily living; decreased soft tissue swelling in joints or tendon sheaths)

Approval duration

6 months initial, 1 year reauth